Search clinical trials for: Histone Deacytelase Inhibitors
Total 64314 results
-
University of WashingtonNational Cancer Institute (NCI); SecuraBioTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedMultiple Myeloma | Nodal Lymphoma | Lymphoma With Cutaneous Involvement | Lymphoma in Leukemic Phase | Marrow Involvement With LymphomaAustralia
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Syndax PharmaceuticalsCompletedNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid... and other conditionsUnited States
-
miRagen Therapeutics, Inc.TerminatedCutaneous T-Cell Lymphoma/Mycosis FungoidesUnited States, France, Spain, Canada, United Kingdom, Australia, Italy, Belgium
-
Yale UniversityMerck Sharp & Dohme LLCTerminatedRelapsed Lymphomas | Refractory LymphomasUnited States
-
Vanderbilt-Ingram Cancer CenterAstraZeneca; Syndax PharmaceuticalsTerminatedFallopian Tube Cancer | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Recurrent Endometrial Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Primary Peritoneal... and other conditionsUnited States
-
Sabine Mueller, MD, PhDPacific Pediatric Neuro-Oncology Consortium; Midatech Pharma US Inc.CompletedDiffuse Intrinsic Pontine GliomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States
-
Cheng-Chia (Fred) WuFocused Ultrasound FoundationActive, not recruitingDiffuse Intrinsic Pontine Glioma | Diffuse Midline Glioma, H3 K27M-Mutant | Diffuse Pontine and Thalamic GliomasUnited States
-
SCRI Development Innovations, LLCNovartis; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
ItalfarmacoTerminatedMultiple MyelomaItaly
-
ItalfarmacoTerminatedChronic Lymphocytic LeukemiaItaly
-
ItalfarmacoTerminatedHodgkin's LymphomaItaly
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCCompletedNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms, Glandular and Epithelial | Digestive System Neoplasms | Endocrine Gland Neoplasms | Breast Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Bronchial Neoplasms | Solid Tumors | Renal...United States
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedMedulloblastoma | Pineoblastoma | Supratentorial Embryonal Tumor, Not Otherwise SpecifiedUnited States
-
Roberto PiliBristol-Myers Squibb; Syndax Pharmaceuticals; Indiana University School of MedicineActive, not recruitingRenal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPreviously Treated Myelodysplastic Syndrome | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Acute Lymphoblastic Leukemia in Remission | Allogeneic Hematopoietic Stem Cell Transplantation RecipientUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
SCRI Development Innovations, LLCNovartisCompleted
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsTerminated
-
Syndax PharmaceuticalsCompletedBreast Cancer | Lung Cancer | Non Small Cell Lung Cancer (NSCLC) | Estrogen Receptor Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center; Merck Sharp & Dohme LLC; Dana-Farber Cancer Institute and other collaboratorsCompletedSolid Tumors | Relapsed/Refractory SarcomasUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologyCompletedFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 3 Endometrial Endometrioid AdenocarcinomaUnited States
-
Emory UniversityMerck Sharp & Dohme LLC; Celgene CorporationCompleted
-
Spectrum Pharmaceuticals, IncOnxeoCompletedPeripheral T-cell LymphomaUnited States, Belgium, United Kingdom, Germany, Spain, Poland, Israel, Netherlands, Canada, Croatia, Denmark, France, Hungary, Italy, Russian Federation, Slovakia, South Africa
-
National Cancer Institute (NCI)CompletedGliosarcoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Diffuse Intrinsic Pontine GliomaUnited States, Canada, Australia
-
State University of New York - Upstate Medical...CompletedBladder Cancer | HematuriaUnited States
-
Acrotech Biopharma Inc.Axis Clinicals LimitedCompletedSolid Tumors | Hematological MalignanciesUnited States
-
Dana-Farber Cancer InstituteNovartisCompletedMultiple Myeloma in RelapseUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCTerminatedBrain Cancer | Glioblastoma MultiformeUnited States
-
Novartis PharmaceuticalsCompletedCutaneous T-Cell LymphomaItaly, Spain, Belgium, Canada, Australia, Germany, Switzerland, United States, France, Argentina, Finland, Hungary
-
Novartis PharmaceuticalsTerminatedCutaneous T-Cell LymphomaUnited States
-
University of LeedsMerck Sharp & Dohme LLC; Myeloma UKCompletedMultiple MyelomaUnited Kingdom
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft Versus Host Disease | GVHDUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Novartis PharmaceuticalsTerminatedMultiple MyelomaUnited States, Germany
-
Taizhou EOC Pharma Co., Ltd.Active, not recruiting
-
Novartis PharmaceuticalsCompletedIdiopathic Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia-Vera MyelofibrosisUnited Kingdom, Ireland, Germany, Italy, France
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
Pamela MunsterPfizer; Xynomic Pharmaceuticals, Inc.WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
ItalfarmacoCompleted